COSCIENS Biopharma Inc. Cash Flows From Used In Financing Activities
COSCIENS Biopharma Inc. (CSCIF) reported Cash Flows From Used In Financing Activities of -$407.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-25
- COSCIENS Biopharma Inc. cash flows from used in financing activities for the quarter ending 2025-12-31 was -$15.00K.
- COSCIENS Biopharma Inc. cash flows from used in financing activities for the quarter ending 2025-09-30 was -$85.00K.
- COSCIENS Biopharma Inc. cash flows from used in financing activities for the quarter ending 2025-06-30 was -$107.00K.
- COSCIENS Biopharma Inc. cash flows from used in financing activities for the quarter ending 2025-03-31 was -$200.00K.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 3 month as first filed | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 6 month as first filed | Cash Flows From Used In Financing Activities 9 month | Cash Flows From Used In Financing Activities 9 month as first filed | Cash Flows From Used In Financing Activities 12 month | Cash Flows From Used In Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$15.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$100.00K derived: sum of 2 quarters · filed 2026-03-25 | -$207.00K derived: sum of 3 quarters · filed 2026-03-25 | -$407.00K 20-F · filed 2026-03-25 | ||||
| 2025-09-30 | -$85.00K 6-K · filed 2025-11-12 | -$192.00K derived: sum of 2 quarters · filed 2025-11-12 | -$392.00K 6-K · filed 2025-11-12 | -$594.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-06-30 | -$107.00K 6-K · filed 2025-08-14 | -$307.00K 6-K · filed 2025-08-14 | -$509.00K derived: sum of 3 quarters · filed 2026-03-25 | -$697.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-03-31 | -$200.00K 6-K · filed 2025-05-13 | -$402.00K derived: sum of 2 quarters · filed 2026-03-25 | -$590.00K derived: sum of 3 quarters · filed 2026-03-25 | -$716.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | -$202.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$390.00K derived: sum of 2 quarters · filed 2026-03-25 | -$516.00K derived: sum of 3 quarters · filed 2026-03-25 | -$588.00K 20-F · filed 2026-03-25 | ||||
| 2024-09-30 | -$188.00K 6-K · filed 2025-11-12 | -$314.00K derived: sum of 2 quarters · filed 2025-11-12 | -$386.00K 6-K · filed 2025-11-12 | -$573.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | -$126.00K 6-K · filed 2025-08-14 | -$198.00K 6-K · filed 2025-08-14 | -$385.00K derived: sum of 3 quarters · filed 2026-03-25 | -$444.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | -$94.00K 6-K · filed 2025-05-13 | -$42.00K 6-K · filed 2024-05-16 | -$259.00K derived: sum of 2 quarters · filed 2026-03-25 | -$318.00K derived: sum of 3 quarters · filed 2026-03-25 | -$388.00K derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2023-12-31 | -$165.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$224.00K derived: sum of 2 quarters · filed 2026-03-25 | -$294.00K derived: sum of 3 quarters · filed 2026-03-25 | -$357.00K 20-F · filed 2026-03-25 | -$151.00K 20-F · filed 2024-03-27 | |||
| 2023-09-30 | -$59.00K 6-K · filed 2024-11-12 | -$33.00K 6-K · filed 2023-11-09 | -$129.00K derived: sum of 2 quarters · filed 2024-11-12 | -$192.00K 6-K · filed 2024-11-12 | -$113.00K 6-K · filed 2023-11-09 | -$333.00K derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-06-30 | -$70.00K 6-K · filed 2024-08-13 | -$42.00K 6-K · filed 2023-08-09 | -$133.00K 6-K · filed 2024-08-13 | -$80.00K 6-K · filed 2023-08-09 | -$274.00K derived: sum of 3 quarters · filed 2025-04-09 | -$307.00K derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-03-31 | -$38.00K 6-K · filed 2024-05-16 | -$204.00K derived: sum of 2 quarters · filed 2025-04-09 | -$237.00K derived: sum of 3 quarters · filed 2025-04-09 | -$271.00K derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2022-12-31 | -$166.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-04-09 | -$199.00K derived: sum of 2 quarters · filed 2025-04-09 | -$233.00K derived: sum of 3 quarters · filed 2025-04-09 | -$267.00K 20-F · filed 2025-04-09 | -$118.00K 20-F · filed 2023-03-23 | |||
| 2022-09-30 | -$33.00K 6-K · filed 2023-11-09 | -$67.00K derived: sum of 2 quarters · filed 2023-11-09 | -$101.00K 6-K · filed 2023-11-09 | $10.00K derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-06-30 | -$34.00K 6-K · filed 2023-08-09 | -$68.00K 6-K · filed 2023-08-09 | $43.00K derived: sum of 3 quarters · filed 2024-07-17 | $12.00K derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-03-31 | -$34.00K 6-K · filed 2023-05-09 | $77.00K derived: sum of 2 quarters · filed 2024-07-17 | $46.00K derived: sum of 3 quarters · filed 2024-07-17 | $70.00K derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2021-12-31 | $111.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $80.00K derived: sum of 2 quarters · filed 2024-07-17 | $104.00K derived: sum of 3 quarters · filed 2024-07-17 | $51.04M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | -$31.00K 6-K · filed 2022-11-03 | -$7.00K derived: sum of 2 quarters · filed 2022-11-03 | $50.93M 6-K · filed 2022-11-03 | $50.91M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-06-30 | $24.00K 6-K/A · filed 2022-08-04 | $50.96M 6-K/A · filed 2022-08-04 | $50.94M derived: sum of 3 quarters · filed 2024-02-15 | $67.73M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-03-31 | $50.93M 6-K · filed 2022-05-11 | $50.92M derived: sum of 2 quarters · filed 2024-02-15 | $67.71M derived: sum of 3 quarters · filed 2024-02-15 | $67.66M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2020-12-31 | -$17.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | $16.78M derived: sum of 2 quarters · filed 2024-02-15 | $16.72M derived: sum of 3 quarters · filed 2024-02-15 | $20.47M 20-F/A · filed 2024-02-15 | ||||
| 2020-09-30 | $16.79M 6-K · filed 2021-11-04 | $16.74M derived: sum of 2 quarters · filed 2021-11-04 | $20.48M 6-K · filed 2021-11-04 | $20.32M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-06-30 | -$52.00K 6-K · filed 2021-08-05 | $3.69M 6-K · filed 2021-08-05 | $3.53M derived: sum of 3 quarters · filed 2022-03-29 | $7.58M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-03-31 | $3.74M 6-K · filed 2021-05-05 | $3.58M derived: sum of 2 quarters · filed 2022-03-29 | $7.63M derived: sum of 3 quarters · filed 2022-03-29 | $7.79M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | -$161.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $3.89M derived: sum of 2 quarters · filed 2022-03-29 | $4.04M derived: sum of 3 quarters · filed 2022-03-29 | $3.89M 20-F · filed 2022-03-29 | ||||
| 2019-09-30 | $4.05M 6-K · filed 2020-11-05 | $4.21M derived: sum of 2 quarters · filed 2020-11-05 | $4.05M 6-K · filed 2020-11-05 | |||||
| 2019-06-30 | $155.00K 6-K · filed 2020-08-06 | $4.00K 6-K · filed 2020-08-06 | ||||||
| 2019-03-31 | -$151.00K 6-K/A · filed 2020-05-11 | |||||||
| 2018-12-31 | $0.00 20-F · filed 2019-04-01 | |||||||
| 2017-12-31 | $8.03M 20-F · filed 2020-03-31 | |||||||
| 2016-12-31 | $9.92M 20-F · filed 2019-04-01 | |||||||
| 2015-12-31 | $40.80M 20-F · filed 2018-03-28 |